This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Michael Kimball Joins IMedX As Chief Revenue Officer

ATLANTA, July 24, 2013 /PRNewswire/ -- iMedX Inc. announced today that Michael Kimball would be joining its ranks as Chief Revenue Officer. The announcement comes on the heels of the company's recent appointment of Christopher Foley as its new Chief Executive Officer.

Michael brings over two decades of executive leadership experience in healthcare to iMedX. Most recently, he served as CEO of Diskriter, Inc., a Health Information Management and Medical Transcription solutions provider. Michael has also held senior leadership roles in Sales, Marketing and Operations with CBay Systems (now known as M*Modal), EDiX Corporation (acquired by Spheris, Inc.) and Kinetic Concepts Inc. Throughout his career, Michael's focus has been to establish a business model that promotes growth through organic sales and acquisitions with an emphasis on client retention, client relations and partner referrals. At iMedX, he will leverage his experience in providing integrated clinical documentation solutions and other related HIM services to hospitals, physician group practices, IDNs and clinics to support the company's rapid growth.

"Mike and I have worked together successfully in the past, and I anticipate even greater accomplishments in the future. iMedX has aggressive goals for expansion, and Mike's comprehensive industry knowledge and deep rooted client relationships provide us with a strategic advantage," said Christopher Foley. "I'm delighted to welcome Mike to the iMedX senior management team and I am excited about the great things we will accomplish with his leadership."

"I am absolutely thrilled to work alongside Chris again and join the iMedX team," said Michael. "The company is well-positioned for continued expansion and I'm looking forward to helping the team realize its full potential as a leader in integrated clinical documentation solutions."

About iMedX

iMedX is a leading healthcare technology company that develops software and solutions for hospitals and acute care facilities across the United States. The company is dedicated to improving the efficiency of physicians and the quality of patient care through robust clinical documentation. With an advanced technology platform, iMedX supports physician adoption of and transition to Electronic Health Record systems while mitigating provider productivity loss and encouraging adherence to health information best practices. Founded in 2002 and headquartered in Atlanta, Georgia, the company has satellite offices nationwide and in India. For more information, please visit


Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $94.19 -1.04%
FB $118.08 0.55%
GOOG $695.81 0.50%
TSLA $234.18 0.80%
YHOO $35.97 -0.11%


Chart of I:DJI
DOW 17,651.26 -99.65 -0.56%
S&P 500 2,051.12 -12.25 -0.59%
NASDAQ 4,725.6390 -37.5850 -0.79%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs